Joined October 2022
- Tweets 1,190
- Following 550
- Followers 899
- Likes 2,172
402 Photos and videos
Herbert Wertheim Cancer Institute Research retweeted
Hopeful news from the world’s largest cancer research meeting @ASCO 💚
New research suggesting some patients may be able to safely skip chemo or avoid more extensive surgery. A fresh approach to brain metastases. And growing evidence that movement matters during treatment.
Progress like this is why we keep showing up.
2
2
188
Herbert Wertheim Cancer Institute Research retweeted
The world's largest cancer research meeting just wrapped in Chicago @ASCO Here are 5 treatment advances people were talking about from a pancreatic cancer drug that nearly doubled median survival, to long-term breast cancer data, to targeted therapies moving earlier in lung cancer. Watch for where treatment is heading.
1
3
244
Survivorship isn't something you're meant to navigate alone. This National Cancer Survivors Month, survivors treated talk about the new family you find within the survivor community and why, even after treatment ends, leaning on each other matters more than ever.
Watch the full episode: youtu.be/5bzxYonE4vU?si=oBqd…
32
A new drug is showing promising results for advanced pancreatic cancer. In a recent clinical trial, daraxonrasib nearly doubled overall survival compared to standard chemotherapy in previously treated metastatic pancreatic cancer patients. pbs.org/newshour/health/panc…
52
Promising research from Dr. Sarbajit Mukherjee at #ASCO26: A phase I study found that neoadjuvant chemokine modulation in resectable metastatic colorectal cancer was safe, feasible, and associated with immune changes in the tumor microenvironment that warrant further study. @Sarbaji85064063
Can we systemically reprogram the tumor microenvironment before surgery?
Excited to present our work at #ASCO2026 on a novel chemokine-modulating regimen in resectable metastatic colorectal cancer.
Building on years of translational research with Dr. Pawel Kalinski, this study explores reshaping the tumor microenvironment to promote anti-tumor immunity.
Key findings:
✅ Safe and feasible neoadjuvant approach
✅ Increased CD8 ratios and favorable intratumoral chemokine changes
These early results suggest that systemic modulation of the tumor microenvironment may strengthen future immunotherapy strategies.
@ASCO @BaptistHealthSF @MiamiCancerInst @UPMC
#CRC #Immunotherapy #TranslationalResearch #GIOncology
1
2
312
Proud to see Dr. Sarbajit Mukherjee, chief of GI medical oncology, for presenting new data from 1,517 phase III solid-tumor trials showing women’s authorship has improved over the past decade, but gaps persist in senior authorship and vary by tumor track. We're proud to see important work advancing equity in oncology research. Well done, @Sarbaji85064063! #ASCO26
🚀 ASCO 2026 is officially underway!
Excited to kick off the meeting by presenting our study on authorship trends in Phase III solid tumor clinical trials presented at #ASCO from 2015–2025.
Grateful to @ASCO for selecting our work and to @AzzaSarfraz and our medical students at @FIU for their incredible contributions that made this project possible.
And this is just Day 1.
Our GI Cancer team at @BaptistHealthSF @MiamiCancerInst will be presenting multiple posters and research updates throughout the meeting. More to come—stay tuned!
@BrainTumorDoc @BrunaPellini @ZouinaS @sawyer_bawek @nihanakkoc
#ASCO2026 #Oncology #CancerResearch #ClinicalTrials #GICancer
1
4
308
Congratulations to the Baptist Health Herbert Wertheim Cancer Institute research teams for their continued contributions to this important work! #ASCO26
1
231
Dr. Sarbajit Mukherjee was featured in @GoHealio as part of ASCO coverage exploring trends in women’s authorship of phase 3 clinical trials. The discussion highlights ongoing conversations around representation in oncology research. healio.com/news/hematology-o…
49
With more men exploring testosterone replacement therapy, understanding treatment options and appropriate medical guidance is important.
Dr. Justin Dubin was featured in @Forbes Health discussing TRT and the role of evidence based care. forbes.com/health/wellness/b…
44
We're proud to recognize Dr. Kyaw Aung, co-author of a landmark publication in The New England Journal of Medicine evaluating daraxonrasib in previously treated advanced RAS-mutated pancreatic ductal adenocarcinoma. @NEJM nejm.org/doi/full/10.1056/NE…
1
2
355
Congratulations to Dr. Kyaw Aung and fellow investigators on this landmark publication in
@NEJM highlighting the high-impact potential of #daraxonrasib in pancreatic cancer.
New in the May 7, 2026, issue of NEJM:
Left Ventricular Unloading in High-Risk PCI (CHIP-BCIS3 trial) nej.md/4lR1vyX
Daraxonrasib in RAS-Mutated Pancreatic Cancer nej.md/4f7xfhX
An mRNA Seasonal Influenza Vaccine in Adults (phase 3 Fluent trial) nej.md/4nfu2z8
Ivermectin and 5% Permethrin Cream for Severe Scabies (GALE CRUSTED trial) nej.md/4tDGSsF
Base Editing of HBG1 and HBG2 Promoters for SCD nej.md/3NZbo13
Subscribe to NEJM for the latest medical research: nej.md/3spfZ1z
ALT Images and descriptions of what's new on NEJM.org this week
3
255
Herbert Wertheim Cancer Institute Research retweeted
Grateful to @FoxNews for allowing me to share my thoughts on pancreatic cancer and on a drug that may meaningfully extend survival for patients.
For decades, KRAS was the “undruggable” engine of PDAC. Seeing RAS-directed therapies finally move the needle is a watershed moment for our field.
At @MiamiCancerInst @BHCancerCare @BaptistHealthSF, we’re excited to build a precision-therapy clinical trials program so every GI cancer patient has a chance to access molecularly targeted options close to home.
noticias.foxnews.com/health/…
#PancreaticCancer #GIOnc #PrecisionOncology #KRAS #ClinicalTrials #RASOn
1
8
626
Key Cancer Insights during the @BaptistHealthSF Biomedical Research Symposium | moderated by Dr. Manmeet Ahluwalia (@BrainTumorDoc) ⬇️
Dr. Joseph Panoff shared data on targeted photon RT benefits vs proton therapy in reconstruction.
Dr. Alessandro Villa (@villa_dds) explained chemoprevention for oral dysplasia.
Dr. Noah Kalman discussed RT-related toxicities in head & neck cancer.
Dr. Delia Constanza Guaqueta highlighted neoadjuvant endocrine therapy to downstage breast tumors.
The discussions highlighted research translating into real-world impact for @BHCancerCare patients.
2
6
387
We’re proud to support the next generation of leaders in radiation oncology physics. Learn more about the #MedPhys residency here: bapth.lt/MedPhys
We're pleased to welcome Cameron Hodges, MSc, to the Medical Physics Residency at @MiamiCancerInst. This two-year program provides advanced clinical training in radiation oncology physics, preparing residents for meaningful careers.
Learn more: bapth.lt/MedPhys
3
174
New data from @ASTRO_org #MRPTS26 presented by @Ganiyani_MD & @RohanGarjeMD reinforce the promise of 177Lu-PSMA-617 in advanced prostate cancer, showing a consistent ability to delay disease progression across randomized trials. Learn More 👇
x.com/MiamiCancerInst/status…
2
3
489